Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Baker Brothers Life Sciences Lp
Relationship:   Director
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   15    
Direct Shares   28,278,373    

Indirect Shares

   99,473,529      
Direct Value   $947,749,846    

Indirect Value

   $2,892,026,755      
Total Shares   127,751,902      
Total Value   $3,839,776,601      


Synageva BioPharma Corp $0 XOMA Corporation $333,213,218 Genomic Health Inc $576,459,614 Acadia Pharmaceuticals Inc $3,178,868 Incyte Corp $7,009,716 Alexion Pharmaceuticals Inc $24,083,248 Beigene Ltd $3,231,765 Kiniksa Pharmaceuticals, Ltd. $573,418 Synageva BioPharma Corp $0 XOMA Corporation $333,213,218 Genomic Health Inc $576,459,614 Acadia Pharmaceuticals Inc $3,178,868 Incyte Corp $7,009,716 Alexion Pharmaceuticals Inc $24,083,248 Beigene Ltd $3,231,765 Kiniksa Pharmaceuticals, Ltd. $573,418
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    13   
    1    

     Stock price went up :
    11   
    0    
     Stock price went down :
    2   
    1    
   
     Gain/Loss Ratio :
   5.5   
   -1.0   
     Percentage Gain/Loss :
   19.7%
 -23.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Synageva BioPharma Corp GEVA Director 2012-07-13 5,077,676 0    Premium*  
            XOMA Corporation XOMA Director 2012-07-19 13,606,093 0    Premium*  
            Genomic Health Inc GHDX Director 2012-07-26 9,086,690 0    Premium*  
            Acadia Pharmaceuticals Inc ACAD Director, 10% Owner 2023-06-01 205,752 2023-06-01 39,330,977    Premium*  
            Seagen Inc SGEN Former 10% Owner, Dire... 2023-12-14 0 2023-12-14 0    Premium*  
            Incyte Corp INCY Director, 10% Owner 2017-09-08 119,681 2017-09-08 822,826    Premium*  
            Aceragen, Inc ACGN Director 0 2014-03-10 1,613,076    Premium*  
            Alexion Pharmaceuticals Inc ALXN Director 2017-06-15 131,963 2017-06-15 1,074,556    Premium*  
            Beigene Ltd BGNE Director, 10% Owner 2023-11-14 20,838 2023-11-14 9,878,124    Premium*  
            Talis Biomedical Corp TLIS Director, 10% Owner 2021-11-18 0 2021-11-18 7,625,425    Premium*  
            Tscan Therapeutics, Inc. TCRX Director, 10% Owner 2022-05-10 0 2022-05-11 2,528,583    Premium*  
            DBV Technologies SA DBVT Director, 10% Owner 2022-06-13 0 2022-06-13 29,190,248    Premium*  
            Kiniksa Pharmaceuticals, Ltd. KNSA Director 2023-06-06 29,680 2023-06-06 2,719,343    Premium*  
            Igm Biosciences, Inc. IGMS Director 2023-06-30 0 2023-09-29 2,896,968    Premium*  
            Madrigal Pharmaceuticals Inc MDGL Director 2023-11-14 0 2023-12-14 1,793,403    Premium*  
* Premium Members only  

Records found :    114         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
SGEN Seagen Inc Director   –       •       •   2017-05-15 4 OE $10.20 $204,000 I/I 20,000 40,895,092 0 -
TLIS Talis Biomedical Corp Director   –       •       •   2021-11-18 4 B $4.37 $218,250 I/I 50,000 7,053,176 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-05-20 4 A $38.82 $287,268 I/I 7,400 38,787,087 0 -
SGEN Seagen Inc Director   –       •       •   2015-05-15 4 A $39.94 $295,556 I/I 7,400 26,054,500 0 -
SGEN Seagen Inc Director   –       •       •   2015-03-10 4 B $34.47 $321,921 I/I 9,319 25,008,136 2.25 -
SGEN Seagen Inc Director   –       •       •   2015-11-10 4 B $44.00 $413,600 I/I 9,400 33,099,494 2.25 -
ACAD Acadia Pharmaceuticals In... Director   –       •       •   2023-05-23 4 OE $17.01 $425,250 I/I 25,000 38,620,261 0 -
INCY Incyte Corp Director   –       •       •   2017-04-27 4 OE $7.26 $435,600 I/I 60,000 787,237 0 -
SGEN Seagen Inc Director   –       •       •   2017-05-19 4 A $66.60 $492,840 I/I 7,400 40,898,792 0 -
ALXN Alexion Pharmaceuticals I... Director   –       •      –    2017-06-14 4 B $118.00 $518,256 I/I 4,392 7,321,850 2.1 -
SGEN Seagen Inc Director   –       •       •   2015-11-18 4 B $43.00 $638,321 I/I 14,638 33,114,132 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-03-01 4 B $31.24 $756,112 I/I 24,200 36,007,250 2.25 -
SGEN Seagen Inc Director   –       •       •   2015-03-04 4 B $34.79 $822,418 I/I 23,621 24,723,100 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-02-26 4 B $30.13 $1,334,945 I/I 44,300 35,758,535 2.25 -
SGEN Seagen Inc Director   –       •       •   2015-05-07 4 B $37.07 $1,772,790 I/I 47,717 26,040,800 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-03-07 4 B $33.68 $2,063,918 I/I 61,265 36,682,540 2.25 -
SGEN Seagen Inc Director   –       •       •   2015-02-25 4 B $34.46 $2,194,758 I/I 63,650 24,274,259 2.25 -
MDGL Madrigal Pharmaceuticals ... Director   –       •      –    2023-11-15 4 B $161.97 $2,461,721 I/I 15,199 1,545,775 2.1 %
TCRX Tscan Therapeutics, Inc. Director   –       •       •   2022-05-10 4 B $1.70 $2,507,804 I/I 1,333,927 2,505,600 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-09-12 4 B $49.84 $2,551,111 I/I 49,889 39,305,533 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-09-07 4 B $47.27 $2,889,689 I/I 59,560 38,840,624 2.25 -
ACAD Acadia Pharmaceuticals In... Director   –       •       •   2023-05-22 4 B $24.46 $3,297,815 I/I 134,206 38,607,761 2.25 %
SGEN Seagen Inc Director   –       •       •   2016-11-07 4 B $58.74 $3,301,345 I/I 56,200 40,590,914 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-02-24 4 B $28.47 $3,696,568 I/I 127,506 35,590,465 2.25 -
MDGL Madrigal Pharmaceuticals ... Director   –       •      –    2023-11-20 4 B $181.93 $3,846,575 I/I 20,709 1,607,668 2.1 %
  114  Records found
  1   2  3   4   5      
  Page 2 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us